Australis Capital is a pharmaceutical public company that develops and helps grow the cannabis industry to meet the growing market demand.
Australis Capital has raised $7.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2022.
Australis Capital's investors include LDA Capital.
Australis Capital is headquartered in Las Vegas, United States.
Australis Capital is a pharmaceutical public company that develops and helps grow the cannabis industry to meet the growing market demand.
Australis Capital is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Australis Capital — Funding & Investors." VCBacked, February 14, 2022, https://www.vcbacked.co/company/australis-capital. Accessed August 14, 2026.
VCBacked. (2022). Australis Capital — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/australis-capital
{{cite web |title=Australis Capital — Funding & Investors |url=https://www.vcbacked.co/company/australis-capital |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated